GE HealthCare Technologies Inc. and the University of California San Francisco and its Department of Radiology and Biomedical Imaging have formed a new relationship to work on innovative scanning and precision cancer, the company said WHY IT MATTERS Building on their history of working up, GE HealthCare announced that the new Care Innovation Hub brings all its collaborative research at UCSF under one framework. The firm said the new gateway will focus on improving medical procedures and increasing access to care by testing and evaluating the use of novel systems for diagnosing and treating disease in medical settings. UCSF medical experts in mental health, neurological condition and oncology will mate with GE analysis and product developers to create imaging services line and precision oncology technologies at university facilities. One of the goals is to further automation, the company said. Such endeavors include improving patient-specific magnetic resonance imaging by leveraging advanced quantitative imaging and remote scanning techniques that could adapt to patient needs in real time and the monitoring patient response to radiopharmaceutical therapies. To expand understanding of brain function, the collaborator will explore the links between white matter injury, vascular disease and Alzheimer’s disease to predict the treatment efficacy for brain health interventions. ” Our collaboration with GE HealthCare brings a practical focus on addressing well-defined clinical objectives,” said Sharmila Majumdar, research vice chair inUCSF’s Department of Radiology & Biomedical Imaging. ” Together, we’re accelerating innovation in ways that will improve access to care and outcomes across healthcare settings. ” THE LARGER TRENDIn previous years, GE and UCSF partnered on technologies to improve radiology efficiencies, such as the Critical Care Suite powered by GE’s healthcare AI X-ray platform to help providersprioritize cases involving collapsed lungs. Artificial intelligence is transforming imaging with the number of U. S. Food and Drug Administration-approved AI tools for imaging numbering more than 300 in just the past few years with health systems partnering with vendors. ON THE RECORD” We’re honored to collaborate with UCSF on this important work, which has the potential to significantly improve patient outcomes and address life-threatening diseases like Alzheimer’s disease and prostate cancer worldwide,” Erin Angel, GE HealthCare’s global vice president of research and scientific affairs, said in a statement. ” By combining our strengths, we’re taking steps toward solutions that meet real clinical needs. Andrea Fox is senior editor of Healthcare IT News.
Email: afox@himss.org
Healthcare IT News is a HIMSS Media publication.